130 related articles for article (PubMed ID: 22226479)
1. Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development.
Sinkus R; Van Beers BE; Vilgrain V; DeSouza N; Waterton JC
Eur J Cancer; 2012 Mar; 48(4):425-31. PubMed ID: 22226479
[TBL] [Abstract][Full Text] [Related]
2. Qualification of imaging biomarkers for oncology drug development.
Waterton JC; Pylkkanen L
Eur J Cancer; 2012 Mar; 48(4):409-15. PubMed ID: 22226478
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance diffusion-weighted imaging: extraneurological applications.
Colagrande S; Carbone SF; Carusi LM; Cova M; Villari N
Radiol Med; 2006 Apr; 111(3):392-419. PubMed ID: 16683086
[TBL] [Abstract][Full Text] [Related]
4. Interest of diffusion-weighted echo-planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: a review.
Levy A; Medjhoul A; Caramella C; Zareski E; Berges O; Chargari C; Boulet B; Bidault F; Dromain C; Balleyguier C
J Magn Reson Imaging; 2011 May; 33(5):1020-7. PubMed ID: 21509857
[TBL] [Abstract][Full Text] [Related]
5. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors.
Razek AA; Megahed AS; Denewer A; Motamed A; Tawfik A; Nada N
Acta Radiol; 2008 Apr; 49(3):364-70. PubMed ID: 18365828
[TBL] [Abstract][Full Text] [Related]
6. Nuclear magnetic resonance (NMR) measurement of the apparent diffusion coefficient (ADC) of tissue water and its relationship to cell volume changes in pathological states.
Sotak CH
Neurochem Int; 2004 Sep; 45(4):569-82. PubMed ID: 15186924
[TBL] [Abstract][Full Text] [Related]
7. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
[TBL] [Abstract][Full Text] [Related]
8. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis.
Wiggermann P; Grützmann R; Weissenböck A; Kamusella P; Dittert DD; Stroszczynski C
Acta Radiol; 2012 Mar; 53(2):135-9. PubMed ID: 22262868
[TBL] [Abstract][Full Text] [Related]
9. The role of diffusion tensor imaging in the evaluation of ischemic brain injury - a review.
Sotak CH
NMR Biomed; 2002; 15(7-8):561-9. PubMed ID: 12489102
[TBL] [Abstract][Full Text] [Related]
10. Applications of diffusion-weighted magnetic resonance imaging in renal cell carcinoma.
Wang H; Zhang X; Ye H
Expert Rev Anticancer Ther; 2011 Jul; 11(7):1017-22. PubMed ID: 21806325
[TBL] [Abstract][Full Text] [Related]
11. Role of diffusion MRI and apparent diffusion coefficient measurement in the diagnosis, staging and pathological classification of bladder tumors.
Dağgülli M; Onur MR; Fırdolaş F; Onur R; Kocakoç E; Orhan İ
Urol Int; 2011; 87(3):346-52. PubMed ID: 21934281
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MR of the brain: methodology and clinical application.
Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N
Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging.
Kremser C; Judmaier W; Hein P; Griebel J; Lukas P; de Vries A
Strahlenther Onkol; 2003 Sep; 179(9):641-9. PubMed ID: 14628131
[TBL] [Abstract][Full Text] [Related]
14. [The clinical application of diffusion weighted magnetic resonance imaging to acute cerebrovascular disorders].
Chu BC; Miyasaka K
No To Shinkei; 1998 Sep; 50(9):787-95. PubMed ID: 9789301
[TBL] [Abstract][Full Text] [Related]
15. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors.
Razek AA; Gaballa G; Denewer A; Nada N
NMR Biomed; 2010 Jul; 23(6):619-23. PubMed ID: 20232453
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment.
Belli P; Costantini M; Ierardi C; Bufi E; Amato D; Mule' A; Nardone L; Terribile D; Bonomo L
Breast J; 2011; 17(6):610-9. PubMed ID: 21929557
[TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted magnetic resonance imaging and its application to cancer.
Charles-Edwards EM; deSouza NM
Cancer Imaging; 2006 Sep; 6(1):135-43. PubMed ID: 17015238
[TBL] [Abstract][Full Text] [Related]
18. Change in diffusion weighted MRI during liver cancer radiotherapy: preliminary observations.
Eccles CL; Haider EA; Haider MA; Fung S; Lockwood G; Dawson LA
Acta Oncol; 2009; 48(7):1034-43. PubMed ID: 19634060
[TBL] [Abstract][Full Text] [Related]
19. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted imaging and apparent diffusion coefficient evaluation of herpes simplex encephalitis and Japanese encephalitis.
Sawlani V
J Neurol Sci; 2009 Dec; 287(1-2):221-6. PubMed ID: 19732907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
